Global AI Lung Screening System Supply, Demand and Key Producers, 2026-2032
The global AI Lung Screening System market size is expected to reach $ 763 million by 2032, rising at a market growth of 11.9% CAGR during the forecast period (2026-2032).
AI Lung Screening System is an integrated software-driven solution that supports early detection and risk stratification of lung cancer?primarily by analyzing low-dose CT (LDCT) scans in screening or incidental nodule workflows. The system typically performs automated lung nodule detection, segmentation, volumetry, growth tracking, malignancy risk scoring, and structured reporting, aiming to reduce radiologist workload, improve consistency, and standardize follow-up recommendations. In practice, it functions as a clinical decision support layer within radiology operations: it flags suspicious findings, prioritizes worklists, and helps quantify change over time. Commercially, ?system? usually refers to a deployable product package (software + workflow integration + validation/regulatory package), rather than an algorithm alone, and is increasingly delivered as a platform with continuous model updates, audit trails, and performance monitoring.
From a multi-angle segmentation standpoint, the market can be parameterized by: (1) Clinical scenario: population LDCT screening vs incidental pulmonary nodules; (2) Algorithmic functions: detection-only, detection+volumetry, full risk scoring (e.g., malignancy probability), and longitudinal tracking; (3) Deployment: on-premise server, private cloud, public cloud/SaaS, or hybrid; (4) Integration depth: standalone viewer vs PACS/RIS embedded workflow with structured reporting; (5) Regulatory class & claims: CAD support vs triage vs quantified decision support. Additional quantitative ?type? parameters include supported CT slice thickness, acceptable dose range, nodule size range (e.g., ?3 mm), sensitivity at fixed false-positive rates, throughput (studies/hour), and interoperability standards (DICOM, HL7/FHIR).
In transaction terms, pricing commonly follows (a) annual subscription per site, (b) per-scan fee, or (c) enterprise license tied to volume tiers, with separate charges for integration, validation support, and service-level agreements. Procurement often runs through hospital IT/security reviews and radiology leadership, with pilots (3?6 months) preceding multi-year contracts. Key trends include tighter workflow embedding (worklist triage + structured reporting), expansion from single-task CAD to end-to-end nodule management, growing emphasis on generalizability and bias control across scanners and populations, and integration of multimodal data (clinical risk factors, prior imaging) to improve risk stratification. As screening volumes rise and radiologist shortages persist, vendors that can prove reduced recall burden, stable false-positive control, and seamless integration are best positioned for durable share gains.
This report studies the global AI Lung Screening System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Lung Screening System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Lung Screening System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Lung Screening System total market, 2021-2032, (USD Million)
Global AI Lung Screening System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Lung Screening System total market, key domestic companies, and share, (USD Million)
Global AI Lung Screening System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Lung Screening System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Lung Screening System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Lung Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lunit, Aidoc, VUNO, Inc., Riverain Technologies, LLC, Viz.ai, RapidAI, Enlitic, ANNALISE-AI PTY LTD, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Lung Screening System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Lung Screening System Market, By Region:
1. How big is the global AI Lung Screening System market?
2. What is the demand of the global AI Lung Screening System market?
3. What is the year over year growth of the global AI Lung Screening System market?
4. What is the total value of the global AI Lung Screening System market?
5. Who are the Major Players in the global AI Lung Screening System market?
6. What are the growth factors driving the market demand?
AI Lung Screening System is an integrated software-driven solution that supports early detection and risk stratification of lung cancer?primarily by analyzing low-dose CT (LDCT) scans in screening or incidental nodule workflows. The system typically performs automated lung nodule detection, segmentation, volumetry, growth tracking, malignancy risk scoring, and structured reporting, aiming to reduce radiologist workload, improve consistency, and standardize follow-up recommendations. In practice, it functions as a clinical decision support layer within radiology operations: it flags suspicious findings, prioritizes worklists, and helps quantify change over time. Commercially, ?system? usually refers to a deployable product package (software + workflow integration + validation/regulatory package), rather than an algorithm alone, and is increasingly delivered as a platform with continuous model updates, audit trails, and performance monitoring.
From a multi-angle segmentation standpoint, the market can be parameterized by: (1) Clinical scenario: population LDCT screening vs incidental pulmonary nodules; (2) Algorithmic functions: detection-only, detection+volumetry, full risk scoring (e.g., malignancy probability), and longitudinal tracking; (3) Deployment: on-premise server, private cloud, public cloud/SaaS, or hybrid; (4) Integration depth: standalone viewer vs PACS/RIS embedded workflow with structured reporting; (5) Regulatory class & claims: CAD support vs triage vs quantified decision support. Additional quantitative ?type? parameters include supported CT slice thickness, acceptable dose range, nodule size range (e.g., ?3 mm), sensitivity at fixed false-positive rates, throughput (studies/hour), and interoperability standards (DICOM, HL7/FHIR).
In transaction terms, pricing commonly follows (a) annual subscription per site, (b) per-scan fee, or (c) enterprise license tied to volume tiers, with separate charges for integration, validation support, and service-level agreements. Procurement often runs through hospital IT/security reviews and radiology leadership, with pilots (3?6 months) preceding multi-year contracts. Key trends include tighter workflow embedding (worklist triage + structured reporting), expansion from single-task CAD to end-to-end nodule management, growing emphasis on generalizability and bias control across scanners and populations, and integration of multimodal data (clinical risk factors, prior imaging) to improve risk stratification. As screening volumes rise and radiologist shortages persist, vendors that can prove reduced recall burden, stable false-positive control, and seamless integration are best positioned for durable share gains.
This report studies the global AI Lung Screening System demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Lung Screening System, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Lung Screening System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Lung Screening System total market, 2021-2032, (USD Million)
Global AI Lung Screening System total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Lung Screening System total market, key domestic companies, and share, (USD Million)
Global AI Lung Screening System revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Lung Screening System total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Lung Screening System total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Lung Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lunit, Aidoc, VUNO, Inc., Riverain Technologies, LLC, Viz.ai, RapidAI, Enlitic, ANNALISE-AI PTY LTD, INFERVISION TECHNOLOGY, Lianying Intelligent Medical Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Lung Screening System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Lung Screening System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lung Cancer Early Screening
- Pulmonary Nodule Detection & Tracking
- High-Risk Population Screening
- Incidental Lung Finding Screening
- Others
- LDCT-based Screening System
- Standard Chest CT AI System
- Others
- On-premise
- Private Cloud (Hospital-owned Cloud)
- Public Cloud / SaaS
- Others
- Medical Institutions
- Great Health Scene
- Lunit
- Aidoc
- VUNO, Inc.
- Riverain Technologies, LLC
- Viz.ai
- RapidAI
- Enlitic
- ANNALISE-AI PTY LTD
- INFERVISION TECHNOLOGY
- Lianying Intelligent Medical Technology
1. How big is the global AI Lung Screening System market?
2. What is the demand of the global AI Lung Screening System market?
3. What is the year over year growth of the global AI Lung Screening System market?
4. What is the total value of the global AI Lung Screening System market?
5. Who are the Major Players in the global AI Lung Screening System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Lung Screening System Introduction
1.2 World AI Lung Screening System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Lung Screening System Total Market by Region (by Headquarter Location)
1.3.1 World AI Lung Screening System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Lung Screening System Revenue (2021-2032)
1.3.3 China Based Company AI Lung Screening System Revenue (2021-2032)
1.3.4 Europe Based Company AI Lung Screening System Revenue (2021-2032)
1.3.5 Japan Based Company AI Lung Screening System Revenue (2021-2032)
1.3.6 South Korea Based Company AI Lung Screening System Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Lung Screening System Revenue (2021-2032)
1.3.8 India Based Company AI Lung Screening System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Lung Screening System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Lung Screening System Consumption Value (2021-2032)
2.2 World AI Lung Screening System Consumption Value by Region
2.2.1 World AI Lung Screening System Consumption Value by Region (2021-2026)
2.2.2 World AI Lung Screening System Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Lung Screening System Consumption Value (2021-2032)
2.4 China AI Lung Screening System Consumption Value (2021-2032)
2.5 Europe AI Lung Screening System Consumption Value (2021-2032)
2.6 Japan AI Lung Screening System Consumption Value (2021-2032)
2.7 South Korea AI Lung Screening System Consumption Value (2021-2032)
2.8 ASEAN AI Lung Screening System Consumption Value (2021-2032)
2.9 India AI Lung Screening System Consumption Value (2021-2032)
3 WORLD AI LUNG SCREENING SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Lung Screening System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Lung Screening System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Lung Screening System in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Lung Screening System in 2025
3.3 AI Lung Screening System Company Evaluation Quadrant
3.4 AI Lung Screening System Market: Overall Company Footprint Analysis
3.4.1 AI Lung Screening System Market: Region Footprint
3.4.2 AI Lung Screening System Market: Company Product Type Footprint
3.4.3 AI Lung Screening System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Lung Screening System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Lung Screening System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Lung Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Lung Screening System Consumption Value Comparison
4.2.1 United States VS China: AI Lung Screening System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Lung Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Lung Screening System Companies and Market Share, 2021-2026
4.3.1 United States Based AI Lung Screening System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Lung Screening System Revenue, (2021-2026)
4.4 China Based Companies AI Lung Screening System Revenue and Market Share, 2021-2026
4.4.1 China Based AI Lung Screening System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Lung Screening System Revenue, (2021-2026)
4.5 Rest of World Based AI Lung Screening System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Lung Screening System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Lung Screening System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Lung Screening System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lung Cancer Early Screening
5.2.2 Pulmonary Nodule Detection & Tracking
5.2.3 High-Risk Population Screening
5.2.4 Incidental Lung Finding Screening
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World AI Lung Screening System Market Size by Type (2021-2026)
5.3.2 World AI Lung Screening System Market Size by Type (2027-2032)
5.3.3 World AI Lung Screening System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY IMAGING MODALITY & DATA SOURCE
6.1 World AI Lung Screening System Market Size Overview by Imaging Modality & Data Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Imaging Modality & Data Source
6.2.1 LDCT-based Screening System
6.2.2 Standard Chest CT AI System
6.2.3 Others
6.3 Market Segment by Imaging Modality & Data Source
6.3.1 World AI Lung Screening System Market Size by Imaging Modality & Data Source (2021-2026)
6.3.2 World AI Lung Screening System Market Size by Imaging Modality & Data Source (2027-2032)
6.3.3 World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source (2027-2032)
7 MARKET ANALYSIS BY DEPLOYMENT & INTEGRATION MODEL
7.1 World AI Lung Screening System Market Size Overview by Deployment & Integration Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Deployment & Integration Model
7.2.1 On-premise
7.2.2 Private Cloud (Hospital-owned Cloud)
7.2.3 Public Cloud / SaaS
7.2.4 Others
7.3 Market Segment by Deployment & Integration Model
7.3.1 World AI Lung Screening System Market Size by Deployment & Integration Model (2021-2026)
7.3.2 World AI Lung Screening System Market Size by Deployment & Integration Model (2027-2032)
7.3.3 World AI Lung Screening System Market Size Market Share by Deployment & Integration Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Lung Screening System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Institutions
8.2.2 Great Health Scene
8.3 Market Segment by Application
8.3.1 World AI Lung Screening System Market Size by Application (2021-2026)
8.3.2 World AI Lung Screening System Market Size by Application (2027-2032)
8.3.3 World AI Lung Screening System Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lunit
9.1.1 Lunit Details
9.1.2 Lunit Major Business
9.1.3 Lunit AI Lung Screening System Product and Services
9.1.4 Lunit AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lunit Recent Developments/Updates
9.1.6 Lunit Competitive Strengths & Weaknesses
9.2 Aidoc
9.2.1 Aidoc Details
9.2.2 Aidoc Major Business
9.2.3 Aidoc AI Lung Screening System Product and Services
9.2.4 Aidoc AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Aidoc Recent Developments/Updates
9.2.6 Aidoc Competitive Strengths & Weaknesses
9.3 VUNO, Inc.
9.3.1 VUNO, Inc. Details
9.3.2 VUNO, Inc. Major Business
9.3.3 VUNO, Inc. AI Lung Screening System Product and Services
9.3.4 VUNO, Inc. AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 VUNO, Inc. Recent Developments/Updates
9.3.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.4 Riverain Technologies, LLC
9.4.1 Riverain Technologies, LLC Details
9.4.2 Riverain Technologies, LLC Major Business
9.4.3 Riverain Technologies, LLC AI Lung Screening System Product and Services
9.4.4 Riverain Technologies, LLC AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Riverain Technologies, LLC Recent Developments/Updates
9.4.6 Riverain Technologies, LLC Competitive Strengths & Weaknesses
9.5 Viz.ai
9.5.1 Viz.ai Details
9.5.2 Viz.ai Major Business
9.5.3 Viz.ai AI Lung Screening System Product and Services
9.5.4 Viz.ai AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viz.ai Recent Developments/Updates
9.5.6 Viz.ai Competitive Strengths & Weaknesses
9.6 RapidAI
9.6.1 RapidAI Details
9.6.2 RapidAI Major Business
9.6.3 RapidAI AI Lung Screening System Product and Services
9.6.4 RapidAI AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 RapidAI Recent Developments/Updates
9.6.6 RapidAI Competitive Strengths & Weaknesses
9.7 Enlitic
9.7.1 Enlitic Details
9.7.2 Enlitic Major Business
9.7.3 Enlitic AI Lung Screening System Product and Services
9.7.4 Enlitic AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Enlitic Recent Developments/Updates
9.7.6 Enlitic Competitive Strengths & Weaknesses
9.8 ANNALISE-AI PTY LTD
9.8.1 ANNALISE-AI PTY LTD Details
9.8.2 ANNALISE-AI PTY LTD Major Business
9.8.3 ANNALISE-AI PTY LTD AI Lung Screening System Product and Services
9.8.4 ANNALISE-AI PTY LTD AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.8.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.9 INFERVISION TECHNOLOGY
9.9.1 INFERVISION TECHNOLOGY Details
9.9.2 INFERVISION TECHNOLOGY Major Business
9.9.3 INFERVISION TECHNOLOGY AI Lung Screening System Product and Services
9.9.4 INFERVISION TECHNOLOGY AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 INFERVISION TECHNOLOGY Recent Developments/Updates
9.9.6 INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
9.10 Lianying Intelligent Medical Technology
9.10.1 Lianying Intelligent Medical Technology Details
9.10.2 Lianying Intelligent Medical Technology Major Business
9.10.3 Lianying Intelligent Medical Technology AI Lung Screening System Product and Services
9.10.4 Lianying Intelligent Medical Technology AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lianying Intelligent Medical Technology Recent Developments/Updates
9.10.6 Lianying Intelligent Medical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Lung Screening System Industry Chain
10.2 AI Lung Screening System Upstream Analysis
10.3 AI Lung Screening System Midstream Analysis
10.4 AI Lung Screening System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 AI Lung Screening System Introduction
1.2 World AI Lung Screening System Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Lung Screening System Total Market by Region (by Headquarter Location)
1.3.1 World AI Lung Screening System Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Lung Screening System Revenue (2021-2032)
1.3.3 China Based Company AI Lung Screening System Revenue (2021-2032)
1.3.4 Europe Based Company AI Lung Screening System Revenue (2021-2032)
1.3.5 Japan Based Company AI Lung Screening System Revenue (2021-2032)
1.3.6 South Korea Based Company AI Lung Screening System Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Lung Screening System Revenue (2021-2032)
1.3.8 India Based Company AI Lung Screening System Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Lung Screening System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Lung Screening System Consumption Value (2021-2032)
2.2 World AI Lung Screening System Consumption Value by Region
2.2.1 World AI Lung Screening System Consumption Value by Region (2021-2026)
2.2.2 World AI Lung Screening System Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Lung Screening System Consumption Value (2021-2032)
2.4 China AI Lung Screening System Consumption Value (2021-2032)
2.5 Europe AI Lung Screening System Consumption Value (2021-2032)
2.6 Japan AI Lung Screening System Consumption Value (2021-2032)
2.7 South Korea AI Lung Screening System Consumption Value (2021-2032)
2.8 ASEAN AI Lung Screening System Consumption Value (2021-2032)
2.9 India AI Lung Screening System Consumption Value (2021-2032)
3 WORLD AI LUNG SCREENING SYSTEM COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Lung Screening System Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Lung Screening System Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Lung Screening System in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Lung Screening System in 2025
3.3 AI Lung Screening System Company Evaluation Quadrant
3.4 AI Lung Screening System Market: Overall Company Footprint Analysis
3.4.1 AI Lung Screening System Market: Region Footprint
3.4.2 AI Lung Screening System Market: Company Product Type Footprint
3.4.3 AI Lung Screening System Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Lung Screening System Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Lung Screening System Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Lung Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Lung Screening System Consumption Value Comparison
4.2.1 United States VS China: AI Lung Screening System Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Lung Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Lung Screening System Companies and Market Share, 2021-2026
4.3.1 United States Based AI Lung Screening System Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Lung Screening System Revenue, (2021-2026)
4.4 China Based Companies AI Lung Screening System Revenue and Market Share, 2021-2026
4.4.1 China Based AI Lung Screening System Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Lung Screening System Revenue, (2021-2026)
4.5 Rest of World Based AI Lung Screening System Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Lung Screening System Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Lung Screening System Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Lung Screening System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lung Cancer Early Screening
5.2.2 Pulmonary Nodule Detection & Tracking
5.2.3 High-Risk Population Screening
5.2.4 Incidental Lung Finding Screening
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World AI Lung Screening System Market Size by Type (2021-2026)
5.3.2 World AI Lung Screening System Market Size by Type (2027-2032)
5.3.3 World AI Lung Screening System Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY IMAGING MODALITY & DATA SOURCE
6.1 World AI Lung Screening System Market Size Overview by Imaging Modality & Data Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Imaging Modality & Data Source
6.2.1 LDCT-based Screening System
6.2.2 Standard Chest CT AI System
6.2.3 Others
6.3 Market Segment by Imaging Modality & Data Source
6.3.1 World AI Lung Screening System Market Size by Imaging Modality & Data Source (2021-2026)
6.3.2 World AI Lung Screening System Market Size by Imaging Modality & Data Source (2027-2032)
6.3.3 World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source (2027-2032)
7 MARKET ANALYSIS BY DEPLOYMENT & INTEGRATION MODEL
7.1 World AI Lung Screening System Market Size Overview by Deployment & Integration Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Deployment & Integration Model
7.2.1 On-premise
7.2.2 Private Cloud (Hospital-owned Cloud)
7.2.3 Public Cloud / SaaS
7.2.4 Others
7.3 Market Segment by Deployment & Integration Model
7.3.1 World AI Lung Screening System Market Size by Deployment & Integration Model (2021-2026)
7.3.2 World AI Lung Screening System Market Size by Deployment & Integration Model (2027-2032)
7.3.3 World AI Lung Screening System Market Size Market Share by Deployment & Integration Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Lung Screening System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Institutions
8.2.2 Great Health Scene
8.3 Market Segment by Application
8.3.1 World AI Lung Screening System Market Size by Application (2021-2026)
8.3.2 World AI Lung Screening System Market Size by Application (2027-2032)
8.3.3 World AI Lung Screening System Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lunit
9.1.1 Lunit Details
9.1.2 Lunit Major Business
9.1.3 Lunit AI Lung Screening System Product and Services
9.1.4 Lunit AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Lunit Recent Developments/Updates
9.1.6 Lunit Competitive Strengths & Weaknesses
9.2 Aidoc
9.2.1 Aidoc Details
9.2.2 Aidoc Major Business
9.2.3 Aidoc AI Lung Screening System Product and Services
9.2.4 Aidoc AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Aidoc Recent Developments/Updates
9.2.6 Aidoc Competitive Strengths & Weaknesses
9.3 VUNO, Inc.
9.3.1 VUNO, Inc. Details
9.3.2 VUNO, Inc. Major Business
9.3.3 VUNO, Inc. AI Lung Screening System Product and Services
9.3.4 VUNO, Inc. AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 VUNO, Inc. Recent Developments/Updates
9.3.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.4 Riverain Technologies, LLC
9.4.1 Riverain Technologies, LLC Details
9.4.2 Riverain Technologies, LLC Major Business
9.4.3 Riverain Technologies, LLC AI Lung Screening System Product and Services
9.4.4 Riverain Technologies, LLC AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Riverain Technologies, LLC Recent Developments/Updates
9.4.6 Riverain Technologies, LLC Competitive Strengths & Weaknesses
9.5 Viz.ai
9.5.1 Viz.ai Details
9.5.2 Viz.ai Major Business
9.5.3 Viz.ai AI Lung Screening System Product and Services
9.5.4 Viz.ai AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Viz.ai Recent Developments/Updates
9.5.6 Viz.ai Competitive Strengths & Weaknesses
9.6 RapidAI
9.6.1 RapidAI Details
9.6.2 RapidAI Major Business
9.6.3 RapidAI AI Lung Screening System Product and Services
9.6.4 RapidAI AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 RapidAI Recent Developments/Updates
9.6.6 RapidAI Competitive Strengths & Weaknesses
9.7 Enlitic
9.7.1 Enlitic Details
9.7.2 Enlitic Major Business
9.7.3 Enlitic AI Lung Screening System Product and Services
9.7.4 Enlitic AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Enlitic Recent Developments/Updates
9.7.6 Enlitic Competitive Strengths & Weaknesses
9.8 ANNALISE-AI PTY LTD
9.8.1 ANNALISE-AI PTY LTD Details
9.8.2 ANNALISE-AI PTY LTD Major Business
9.8.3 ANNALISE-AI PTY LTD AI Lung Screening System Product and Services
9.8.4 ANNALISE-AI PTY LTD AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.8.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.9 INFERVISION TECHNOLOGY
9.9.1 INFERVISION TECHNOLOGY Details
9.9.2 INFERVISION TECHNOLOGY Major Business
9.9.3 INFERVISION TECHNOLOGY AI Lung Screening System Product and Services
9.9.4 INFERVISION TECHNOLOGY AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 INFERVISION TECHNOLOGY Recent Developments/Updates
9.9.6 INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
9.10 Lianying Intelligent Medical Technology
9.10.1 Lianying Intelligent Medical Technology Details
9.10.2 Lianying Intelligent Medical Technology Major Business
9.10.3 Lianying Intelligent Medical Technology AI Lung Screening System Product and Services
9.10.4 Lianying Intelligent Medical Technology AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lianying Intelligent Medical Technology Recent Developments/Updates
9.10.6 Lianying Intelligent Medical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Lung Screening System Industry Chain
10.2 AI Lung Screening System Upstream Analysis
10.3 AI Lung Screening System Midstream Analysis
10.4 AI Lung Screening System Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World AI Lung Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Lung Screening System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Lung Screening System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Lung Screening System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Lung Screening System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Lung Screening System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Lung Screening System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Lung Screening System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Lung Screening System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Lung Screening System Players in 2025
Table 12. World AI Lung Screening System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Lung Screening System Company Evaluation Quadrant
Table 14. Head Office of Key AI Lung Screening System Players
Table 15. AI Lung Screening System Market: Company Product Type Footprint
Table 16. AI Lung Screening System Market: Company Product Application Footprint
Table 17. AI Lung Screening System Mergers & Acquisitions Activity
Table 18. United States VS China AI Lung Screening System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Lung Screening System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Lung Screening System Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Lung Screening System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 23. China Based AI Lung Screening System Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Lung Screening System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Lung Screening System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Lung Screening System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 29. World AI Lung Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Lung Screening System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Lung Screening System Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Lung Screening System Market Size by Imaging Modality & Data Source, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Lung Screening System Market Size Value by Imaging Modality & Data Source (2021-2026) & (USD Million)
Table 34. World AI Lung Screening System Market Size by Imaging Modality & Data Source (2027-2032) & (USD Million)
Table 35. World AI Lung Screening System Market Size by Deployment & Integration Model, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Lung Screening System Market Size Value by Deployment & Integration Model (2021-2026) & (USD Million)
Table 37. World AI Lung Screening System Market Size by Deployment & Integration Model (2027-2032) & (USD Million)
Table 38. World AI Lung Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Lung Screening System Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Lung Screening System Market Size by Application (2027-2032) & (USD Million)
Table 41. Lunit Basic Information, Manufacturing Base and Competitors
Table 42. Lunit Major Business
Table 43. Lunit AI Lung Screening System Product and Services
Table 44. Lunit AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lunit Recent Developments/Updates
Table 46. Lunit Competitive Strengths & Weaknesses
Table 47. Aidoc Basic Information, Manufacturing Base and Competitors
Table 48. Aidoc Major Business
Table 49. Aidoc AI Lung Screening System Product and Services
Table 50. Aidoc AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Aidoc Recent Developments/Updates
Table 52. Aidoc Competitive Strengths & Weaknesses
Table 53. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. VUNO, Inc. Major Business
Table 55. VUNO, Inc. AI Lung Screening System Product and Services
Table 56. VUNO, Inc. AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. VUNO, Inc. Recent Developments/Updates
Table 58. VUNO, Inc. Competitive Strengths & Weaknesses
Table 59. Riverain Technologies, LLC Basic Information, Manufacturing Base and Competitors
Table 60. Riverain Technologies, LLC Major Business
Table 61. Riverain Technologies, LLC AI Lung Screening System Product and Services
Table 62. Riverain Technologies, LLC AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Riverain Technologies, LLC Recent Developments/Updates
Table 64. Riverain Technologies, LLC Competitive Strengths & Weaknesses
Table 65. Viz.ai Basic Information, Manufacturing Base and Competitors
Table 66. Viz.ai Major Business
Table 67. Viz.ai AI Lung Screening System Product and Services
Table 68. Viz.ai AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viz.ai Recent Developments/Updates
Table 70. Viz.ai Competitive Strengths & Weaknesses
Table 71. RapidAI Basic Information, Manufacturing Base and Competitors
Table 72. RapidAI Major Business
Table 73. RapidAI AI Lung Screening System Product and Services
Table 74. RapidAI AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. RapidAI Recent Developments/Updates
Table 76. RapidAI Competitive Strengths & Weaknesses
Table 77. Enlitic Basic Information, Manufacturing Base and Competitors
Table 78. Enlitic Major Business
Table 79. Enlitic AI Lung Screening System Product and Services
Table 80. Enlitic AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Enlitic Recent Developments/Updates
Table 82. Enlitic Competitive Strengths & Weaknesses
Table 83. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 84. ANNALISE-AI PTY LTD Major Business
Table 85. ANNALISE-AI PTY LTD AI Lung Screening System Product and Services
Table 86. ANNALISE-AI PTY LTD AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 88. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 89. INFERVISION TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 90. INFERVISION TECHNOLOGY Major Business
Table 91. INFERVISION TECHNOLOGY AI Lung Screening System Product and Services
Table 92. INFERVISION TECHNOLOGY AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. INFERVISION TECHNOLOGY Recent Developments/Updates
Table 94. INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
Table 95. Lianying Intelligent Medical Technology Basic Information, Manufacturing Base and Competitors
Table 96. Lianying Intelligent Medical Technology Major Business
Table 97. Lianying Intelligent Medical Technology AI Lung Screening System Product and Services
Table 98. Lianying Intelligent Medical Technology AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lianying Intelligent Medical Technology Recent Developments/Updates
Table 100. Lianying Intelligent Medical Technology Competitive Strengths & Weaknesses
Table 101. Global Key Players of AI Lung Screening System Upstream (Raw Materials)
Table 102. Global AI Lung Screening System Typical Customers
Table 1. World AI Lung Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Lung Screening System Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Lung Screening System Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Lung Screening System Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Lung Screening System Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Lung Screening System Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Lung Screening System Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Lung Screening System Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Lung Screening System Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Lung Screening System Players in 2025
Table 12. World AI Lung Screening System Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Lung Screening System Company Evaluation Quadrant
Table 14. Head Office of Key AI Lung Screening System Players
Table 15. AI Lung Screening System Market: Company Product Type Footprint
Table 16. AI Lung Screening System Market: Company Product Application Footprint
Table 17. AI Lung Screening System Mergers & Acquisitions Activity
Table 18. United States VS China AI Lung Screening System Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Lung Screening System Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Lung Screening System Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Lung Screening System Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 23. China Based AI Lung Screening System Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Lung Screening System Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Lung Screening System Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Lung Screening System Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Lung Screening System Revenue Market Share (2021-2026)
Table 29. World AI Lung Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Lung Screening System Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Lung Screening System Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Lung Screening System Market Size by Imaging Modality & Data Source, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Lung Screening System Market Size Value by Imaging Modality & Data Source (2021-2026) & (USD Million)
Table 34. World AI Lung Screening System Market Size by Imaging Modality & Data Source (2027-2032) & (USD Million)
Table 35. World AI Lung Screening System Market Size by Deployment & Integration Model, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Lung Screening System Market Size Value by Deployment & Integration Model (2021-2026) & (USD Million)
Table 37. World AI Lung Screening System Market Size by Deployment & Integration Model (2027-2032) & (USD Million)
Table 38. World AI Lung Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Lung Screening System Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Lung Screening System Market Size by Application (2027-2032) & (USD Million)
Table 41. Lunit Basic Information, Manufacturing Base and Competitors
Table 42. Lunit Major Business
Table 43. Lunit AI Lung Screening System Product and Services
Table 44. Lunit AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lunit Recent Developments/Updates
Table 46. Lunit Competitive Strengths & Weaknesses
Table 47. Aidoc Basic Information, Manufacturing Base and Competitors
Table 48. Aidoc Major Business
Table 49. Aidoc AI Lung Screening System Product and Services
Table 50. Aidoc AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Aidoc Recent Developments/Updates
Table 52. Aidoc Competitive Strengths & Weaknesses
Table 53. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. VUNO, Inc. Major Business
Table 55. VUNO, Inc. AI Lung Screening System Product and Services
Table 56. VUNO, Inc. AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. VUNO, Inc. Recent Developments/Updates
Table 58. VUNO, Inc. Competitive Strengths & Weaknesses
Table 59. Riverain Technologies, LLC Basic Information, Manufacturing Base and Competitors
Table 60. Riverain Technologies, LLC Major Business
Table 61. Riverain Technologies, LLC AI Lung Screening System Product and Services
Table 62. Riverain Technologies, LLC AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Riverain Technologies, LLC Recent Developments/Updates
Table 64. Riverain Technologies, LLC Competitive Strengths & Weaknesses
Table 65. Viz.ai Basic Information, Manufacturing Base and Competitors
Table 66. Viz.ai Major Business
Table 67. Viz.ai AI Lung Screening System Product and Services
Table 68. Viz.ai AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Viz.ai Recent Developments/Updates
Table 70. Viz.ai Competitive Strengths & Weaknesses
Table 71. RapidAI Basic Information, Manufacturing Base and Competitors
Table 72. RapidAI Major Business
Table 73. RapidAI AI Lung Screening System Product and Services
Table 74. RapidAI AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. RapidAI Recent Developments/Updates
Table 76. RapidAI Competitive Strengths & Weaknesses
Table 77. Enlitic Basic Information, Manufacturing Base and Competitors
Table 78. Enlitic Major Business
Table 79. Enlitic AI Lung Screening System Product and Services
Table 80. Enlitic AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Enlitic Recent Developments/Updates
Table 82. Enlitic Competitive Strengths & Weaknesses
Table 83. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 84. ANNALISE-AI PTY LTD Major Business
Table 85. ANNALISE-AI PTY LTD AI Lung Screening System Product and Services
Table 86. ANNALISE-AI PTY LTD AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 88. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 89. INFERVISION TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 90. INFERVISION TECHNOLOGY Major Business
Table 91. INFERVISION TECHNOLOGY AI Lung Screening System Product and Services
Table 92. INFERVISION TECHNOLOGY AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. INFERVISION TECHNOLOGY Recent Developments/Updates
Table 94. INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
Table 95. Lianying Intelligent Medical Technology Basic Information, Manufacturing Base and Competitors
Table 96. Lianying Intelligent Medical Technology Major Business
Table 97. Lianying Intelligent Medical Technology AI Lung Screening System Product and Services
Table 98. Lianying Intelligent Medical Technology AI Lung Screening System Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lianying Intelligent Medical Technology Recent Developments/Updates
Table 100. Lianying Intelligent Medical Technology Competitive Strengths & Weaknesses
Table 101. Global Key Players of AI Lung Screening System Upstream (Raw Materials)
Table 102. Global AI Lung Screening System Typical Customers
LIST OF FIGURES
Figure 1. AI Lung Screening System Picture
Figure 2. World AI Lung Screening System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Lung Screening System Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Lung Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Lung Screening System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 13. AI Lung Screening System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Lung Screening System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Lung Screening System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Lung Screening System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Lung Screening System Markets in 2025
Figure 27. United States VS China: AI Lung Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Lung Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Lung Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Lung Screening System Market Size Market Share by Type in 2025
Figure 31. Lung Cancer Early Screening
Figure 32. Pulmonary Nodule Detection & Tracking
Figure 33. High-Risk Population Screening
Figure 34. Incidental Lung Finding Screening
Figure 35. Others
Figure 36. World AI Lung Screening System Market Size Market Share by Type (2021-2032)
Figure 37. World AI Lung Screening System Market Size by Imaging Modality & Data Source, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source in 2025
Figure 39. LDCT-based Screening System
Figure 40. Standard Chest CT AI System
Figure 41. Others
Figure 42. World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source (2021-2032)
Figure 43. World AI Lung Screening System Market Size by Deployment & Integration Model, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI Lung Screening System Market Size Market Share by Deployment & Integration Model in 2025
Figure 45. On-premise
Figure 46. Private Cloud (Hospital-owned Cloud)
Figure 47. Public Cloud / SaaS
Figure 48. Others
Figure 49. World AI Lung Screening System Market Size Market Share by Deployment & Integration Model (2021-2032)
Figure 50. World AI Lung Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI Lung Screening System Market Size Market Share by Application in 2025
Figure 52. Medical Institutions
Figure 53. Great Health Scene
Figure 54. World AI Lung Screening System Market Size Market Share by Application (2021-2032)
Figure 55. AI Lung Screening System Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. AI Lung Screening System Picture
Figure 2. World AI Lung Screening System Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Lung Screening System Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Lung Screening System Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Lung Screening System Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Lung Screening System Revenue (2021-2032) & (USD Million)
Figure 13. AI Lung Screening System Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Lung Screening System Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Lung Screening System Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Lung Screening System by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Lung Screening System Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Lung Screening System Markets in 2025
Figure 27. United States VS China: AI Lung Screening System Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Lung Screening System Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Lung Screening System Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Lung Screening System Market Size Market Share by Type in 2025
Figure 31. Lung Cancer Early Screening
Figure 32. Pulmonary Nodule Detection & Tracking
Figure 33. High-Risk Population Screening
Figure 34. Incidental Lung Finding Screening
Figure 35. Others
Figure 36. World AI Lung Screening System Market Size Market Share by Type (2021-2032)
Figure 37. World AI Lung Screening System Market Size by Imaging Modality & Data Source, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source in 2025
Figure 39. LDCT-based Screening System
Figure 40. Standard Chest CT AI System
Figure 41. Others
Figure 42. World AI Lung Screening System Market Size Market Share by Imaging Modality & Data Source (2021-2032)
Figure 43. World AI Lung Screening System Market Size by Deployment & Integration Model, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI Lung Screening System Market Size Market Share by Deployment & Integration Model in 2025
Figure 45. On-premise
Figure 46. Private Cloud (Hospital-owned Cloud)
Figure 47. Public Cloud / SaaS
Figure 48. Others
Figure 49. World AI Lung Screening System Market Size Market Share by Deployment & Integration Model (2021-2032)
Figure 50. World AI Lung Screening System Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World AI Lung Screening System Market Size Market Share by Application in 2025
Figure 52. Medical Institutions
Figure 53. Great Health Scene
Figure 54. World AI Lung Screening System Market Size Market Share by Application (2021-2032)
Figure 55. AI Lung Screening System Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
